Unmet Psychosocial Needs of Patients with Newly Diagnosed Ulcerative Colitis: Results from the Nationwide Prospective Cohort Study in Korea.
Anxiety
Colitis
Depression
Patient reported outcome measures
Quality of life
ulcerative
Journal
Gut and liver
ISSN: 2005-1212
Titre abrégé: Gut Liver
Pays: Korea (South)
ID NLM: 101316452
Informations de publication
Date de publication:
15 07 2020
15 07 2020
Historique:
received:
30
03
2019
revised:
12
07
2019
accepted:
31
07
2019
pubmed:
20
9
2019
medline:
14
9
2021
entrez:
20
9
2019
Statut:
ppublish
Résumé
Limited data are available regarding psychosocial distress at the time of diagnosis of ulcerative colitis (UC). We investigated the psychosocial burden and factors related to poor health-related quality of life (HRQL) among patients newly diagnosed with moderate-to-severe UC who were affiliated with the nationwide prospective cohort study. Within the first 4 weeks of UC diagnosis, all patients were assessed using the Hospital Anxiety and Depression Scale (HADS), Work Productivity and Activity Impairment questionnaire, Inflammatory Bowel Disease Questionnaire (IBDQ), and 12-Item Short Form (SF-12) health survey. A multiple linear regression model was used to identify factors associated with HRQL. Between August 2014 and February 2017, 355 patients completed questionnaires. Significant mood disorders requiring psychological interventions, defined by a HADS score ≥11, were identified in 16.7% (anxiety) and 20.6% (depression) of patients. Patients with severe disease were more likely to have presenteeism, loss of work productivity, and activity loss than those with moderate disease (all p<0.05). Significant mood disorders had the strongest negative relationship with total IBDQ score, which indicates disease-specific HRQL (β coefficient: -22.1 for depression and -40.0 for anxiety, p<0.001). The scores of all SF-12 dimensions, which indicate general HRQL, were remarkably decreased in the study population compared indirectly with previously reported scores in the general population. The Mayo score, C-reactive protein level, and white blood cell count showed significant negative associations with the IBDQ score (p<0.05). Psychosocial screening and timely interventions should be incorporated into the initial care of patients newly diagnosed with UC.
Sections du résumé
Background/Aims
Limited data are available regarding psychosocial distress at the time of diagnosis of ulcerative colitis (UC). We investigated the psychosocial burden and factors related to poor health-related quality of life (HRQL) among patients newly diagnosed with moderate-to-severe UC who were affiliated with the nationwide prospective cohort study.
Methods
Within the first 4 weeks of UC diagnosis, all patients were assessed using the Hospital Anxiety and Depression Scale (HADS), Work Productivity and Activity Impairment questionnaire, Inflammatory Bowel Disease Questionnaire (IBDQ), and 12-Item Short Form (SF-12) health survey. A multiple linear regression model was used to identify factors associated with HRQL.
Results
Between August 2014 and February 2017, 355 patients completed questionnaires. Significant mood disorders requiring psychological interventions, defined by a HADS score ≥11, were identified in 16.7% (anxiety) and 20.6% (depression) of patients. Patients with severe disease were more likely to have presenteeism, loss of work productivity, and activity loss than those with moderate disease (all p<0.05). Significant mood disorders had the strongest negative relationship with total IBDQ score, which indicates disease-specific HRQL (β coefficient: -22.1 for depression and -40.0 for anxiety, p<0.001). The scores of all SF-12 dimensions, which indicate general HRQL, were remarkably decreased in the study population compared indirectly with previously reported scores in the general population. The Mayo score, C-reactive protein level, and white blood cell count showed significant negative associations with the IBDQ score (p<0.05).
Conclusions
Psychosocial screening and timely interventions should be incorporated into the initial care of patients newly diagnosed with UC.
Identifiants
pubmed: 31533398
pii: gnl19107
doi: 10.5009/gnl19107
pmc: PMC7366148
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
459-467Commentaires et corrections
Type : CommentIn
Type : ErratumIn
Références
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
BMC Public Health. 2014 Oct 18;14:1086
pubmed: 25326684
J Crohns Colitis. 2014 Jul;8(7):598-606
pubmed: 24345767
Intest Res. 2019 Jan;17(1):1-5
pubmed: 30678443
Gastroenterology. 1989 Mar;96(3):804-10
pubmed: 2644154
Aliment Pharmacol Ther. 2017 Jan;45(2):264-275
pubmed: 27859410
Inflamm Bowel Dis. 2005 Jan;11(1):24-34
pubmed: 15674110
Gastroenterology. 2018 Apr;154(5):1249-1257
pubmed: 29410117
J Clin Gastroenterol. 2013 Apr;47(4):e38-44
pubmed: 23090047
Scand J Gastroenterol. 2009;44(4):431-40
pubmed: 19101844
Inflamm Bowel Dis. 2016 Aug;22(8):1971-80
pubmed: 27135486
Clin Gastroenterol Hepatol. 2014 Aug;12(8):1246-56.e6
pubmed: 24534550
J Gastroenterol Hepatol. 2018 Apr;33(4):847-854
pubmed: 29055148
Inflamm Bowel Dis. 2008 Apr;14(4):554-65
pubmed: 17973299
Gut. 2018 Feb;67(2):244-254
pubmed: 27780886
Aliment Pharmacol Ther. 2013 Nov;38(9):1097-108
pubmed: 24099471
Gastroenterology. 1994 Feb;106(2):287-96
pubmed: 8299896
Inflamm Bowel Dis. 2004 May;10(3):261-9
pubmed: 15290922
Inflamm Bowel Dis. 2016 Jul;22(7):1679-87
pubmed: 27206016
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Dig Dis. 2016;34(1-2):58-63
pubmed: 26983009
Inflamm Bowel Dis. 2016 Mar;22(3):752-62
pubmed: 26841224
J Crohns Colitis. 2017 Feb;11(2):165-174
pubmed: 27516406
Clin Gastroenterol Hepatol. 2017 Jul;15(7):986-997
pubmed: 28300693
Aliment Pharmacol Ther. 2014 Apr;39(8):811-22
pubmed: 24612278
Inflamm Bowel Dis. 2014 Jan;20(1):92-102
pubmed: 24193152
Gastroenterology. 2007 Feb;132(2):763-86
pubmed: 17258735
Front Psychiatry. 2018 Aug 03;9:324
pubmed: 30127753
J Crohns Colitis. 2007 Sep;1(1):10-20
pubmed: 21172179
Pharmacoeconomics. 1993 Nov;4(5):353-65
pubmed: 10146874
Inflamm Bowel Dis. 2015 Mar;21(3):623-30
pubmed: 25647154
Intest Res. 2017 Jul;15(3):338-344
pubmed: 28670230
Am J Gastroenterol. 2017 Jun;112(6):825-827
pubmed: 28508869
Inflamm Bowel Dis. 2012 Mar;18(3):496-505
pubmed: 21509908
Dig Dis Sci. 2017 Dec;62(12):3563-3567
pubmed: 29052816
J Crohns Colitis. 2018 Apr 27;12(5):600-609
pubmed: 29718244
Best Pract Res Clin Gastroenterol. 2014 Jun;28(3):363-72
pubmed: 24913377
Inflamm Bowel Dis. 2018 Aug 16;24(9):1867-1875
pubmed: 29668911
Am J Gastroenterol. 2008 Aug;103(8):1989-97
pubmed: 18796096
Inflamm Bowel Dis. 2012 Aug;18(8):1540-9
pubmed: 21936030
Inflamm Bowel Dis. 2018 Nov 29;24(12):2550-2554
pubmed: 29920581
BMC Psychiatry. 2012 Dec 14;12:227
pubmed: 23237076
N Engl J Med. 1987 Dec 24;317(26):1625-9
pubmed: 3317057
Gut Liver. 2017 May 15;11(3):370-376
pubmed: 28208008
PLoS One. 2015 Apr 27;10(4):e0124211
pubmed: 25915777
J Gastroenterol. 2017 May;52(5):555-567
pubmed: 27470433